Our Vision:

The International Myeloma Foundation (IMF) and our International Myeloma Working Group (IMWG) are proud to announce Dr. Sagar Lonial as this year’s Robert A. Kyle Achievement Award recipient and Dr. Sonja Zweegman as this year’s Brian G.M. Durie Outstanding Achievement Award recipient. The in-person awards ceremony will be held on Tuesday, June 10, at the 16th Annual International Myeloma Working Group (IMWG) Summit in Milano, Italy.  These visionary leaders were recognized for their pivotal contributions to multiple myeloma treatments, research, and patient care. 

From Atlanta to Amsterdam, their work is transforming lives and shaping the future of myeloma care across the globe. Read the full press release to learn more about their inspiring achievements. READ THE PRESS RELEASE.

Published in the Journal of Clinical Oncology, the peer-reviewed article, “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma” is a collaborative effort among the world’s finest myeloma researchers and experts to provide “the first consensus definition of high-risk multiple myeloma in the contemporary era of genomics.” Among the authors of the peer-reviewed article are IMF Chairperson of the Board S. Vincent Rajkumar, MD; and IMF Scientific Advisory Board Members: IMWG Scientific Committee Member and IMS Past President Nikhil Munshi, MD (Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute—Boston, MA); IMS President, IMWG Scientific and Steering Committee Member Philippe Moreau, MD (University Hospital of Nantes — Nantes, France); Saad Z. Usmani, MD, MBA, FACP, FASCO (Memorial Sloan Kettering Cancer Center — New York, NY); Asian Myeloma Network Executive Committee Chairperson Wee Joo Chng, MD (National University Cancer Institute, National University Health System; and National University of Singapore—Singapore); Sagar Lonial MD, FACP (Winship Cancer Institute, Emory University — Atlanta, GA); María-Victoria Mateos, MD, PhD (University of Salamanca — Salamanca, Spain); and Shaji Kumar, MD (Mayo Clinic — Rochester, MN). To learn more, read the news release. READ THE NEWS RELEASE.

The Next Las Voces de Mieloma (Spanish/virtual) Support Group is on June 17, 2025 from 10 a.m.-11 a.m. PST. Guest speaker / Oradora invitada: Dr. Pooja Phull, John Theurer Cancer Center affiliated with Hackensack University Medical Center, NJ. Topic: Symptom management for patients living with Multiple Myeloma | Manejo de los síntomas para pacientes viviendo con mieloma múltiple

Dr. Pooja Phull – John Theurer Cancer Center affiliated with Hackensack University Medical Center, NJ

Dr. Phull is a board-certified hematologist/oncologist who specializes in caring for patients with multiple myeloma and related cancers. She is committed to providing high quality, personalized care to each individual patient and their family. She graduated from Tufts University with a dual major in Spanish and Community Health prior to earning her degree in medicine from Tufts University School of Medicine. She subsequently completed her residency in internal medicine at Boston Medical Center prior to serving as an Instructor in Medicine at the Amyloidosis Center at Boston University School of Medicine. She completed her fellowship in hematology/medical oncology at Fox Chase Cancer Center/Temple University Hospital. She is currently practicing as a physician in the myeloma division at the John Theurer Cancer Center affiliated with Hackensack University Medical Center in New Jersey. Throughout her training and practice, she has integrated her dedication to serving underserved populations with her passion for the science of medicine. REGISTER NOW. 

Dr. Pooja Phull - John Theurer Cancer Center afiliado con Hackensack University Medical Center, NJ.

Dr. Phull es una hematologia/oncologa certificada por la junta medica que especializa en cuidar por pacientes con mieloma y otros canceres relacionados. Ella es cometida a proporcionando cuidado de alta calidad que es adaptada a cada paciente individual. Ella concentro en Espanol y Salud Publica en Tufts University antes de ganar su licenciatura de medicina de La Escuela de Medicina de Tufts University. Despues de eso, ella completo su residencia de medicina en Boston Medical Center y sirvio como Instructora de Medicina en el Centro de Amyloidosis de la Escuela de Medicina de Boston University. Ella completo su especializacion en hematologia/oncologia en at Fox Chase Cancer Center/Temple University Hospital. Ella es una medica en la division de mieloma multiple en el John Theurer Cancer Center que es afiliado con Hackensack University Medical Center en Nueva Jersey. Durante su capacitacion y practica de la medicina, ella ha integrado su dedicacion a server a pacientes desatendidas con su pasion por la sciencia de medicina REGISTRESE AHORA. 

On Tuesday, June 17, IMF Chief Medical Officer Joseph Mikhael MD, MEd, FRCPC, FACP, FASCO (TGen, City of Hope Cancer Center — Phoenix, AZ), will discuss the latest news in drug therapy from the June 2025 American Society of Clinical Oncology (ASCO) Annual Conference, the IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference along with a panel of leading myeloma experts: IMF Nurse Leadership Board Member Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN (Cleveland Clinic Taussig Cancer Institute — Cleveland, OH); Sagar Lonial, MD, FACP (Winship Cancer Institute, Emory University School of Medicine — Atlanta, GA); and María-Victoria Mateos, MD, PhD (University of Salamanca—Salamanca, Spain). During this webinar, the panel and Dr. Mikhael will focus on the following topics: MGUS and Smoldering Multiple Myeloma(SMM); Updates in Frontline Therapy; The Evolution of CAR T-Cell Therapy; Novel Immune Therapies; MRD Testing and Its Role in Myeloma Working Committee Report. Join us LIVE on Tuesday, June 17, at 3:00 PM PST | 5:00 PM CT | 6:00 PM ET. You won’t want to miss this lively discussion. Be at the forefront of the latest myeloma research! REGISTER NOW.

Join the IMF for a Seattle Community Workshop on August 9, 2025, at the Graduate by Hilton (4507 Brooklyn Ave NE).  Don’t miss this unique opportunity to connect with leading myeloma specialists in a supportive, in-person setting. 

During the event, experts will cover key topics, including myeloma basics, upfront treatments at diagnosis, maintenance therapy, and what to know about relapse. A member of the IMF Nurse Leadership Board will also provide insights on managing side effects and symptoms. Plus, attendees will have the opportunity to ask questions directly to the specialists. Click on the following link for updates on this event: REGISTER NOW.

The International Myeloma Foundation (IMF) is excited to announce that the 2025 Los Angeles Patient and Family Seminar will take place at the Hilton Los Angeles/Universal City (555 Universal Hollywood Drive) on August 15-16, 2025. IMF Team members who will speak at this seminar include IMF Vice President of Development Sylvia Dsouza; IMF Vice President of Support Groups Robin Tuohy; IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; and twenty-five-year myeloma survivor Michael Tuohy. Additional myeloma experts and a keynote speaker will be announced soon. The seminar is FREE, but in-person seating is LIMITED. REGISTER NOW.